Oppenheimer Maintains Outperform on PACS Group, Raises Price Target to $48
PACS Group, Inc.
PACS Group, Inc. PACS | 0.00 |
Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:
PACS) with a Outperform and raises the price target from $42 to $48.